Usage: CETRAXAL is a quinolone antimicrobial indicated for treating acute otitis externa caused by susceptible strains of Pseudomonas aeruginosa and Staphylococcus aureus.
Usage: Ciprofloxacin and dexamethasone otic suspension is indicated for treating acute otitis externa in pediatric (6 months and older), adult, and elderly patients due to infections from susceptible strains of Staphylococcus aureus and Pseudomonas aeruginosa.
Usage: Ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension is indicated for treating acute otitis externa (AOE) in patients aged 6 months and older, caused by susceptible strains of Staphylococcus aureus and Pseudomonas aeruginosa.
Usage: Ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension is indicated for treating acute otitis media in pediatric patients with tympanostomy tubes and acute otitis externa in pediatric, adult, and elderly patients, caused by specified susceptible bacteria, including Staphylococcus aureus and Pseudomonas aeruginosa.
Usage: Ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension is indicated for treating acute otitis media in pediatric patients with tympanostomy tubes and acute otitis externa in pediatric, adult, and elderly patients, caused by specific susceptible microorganisms, including Staphylococcus aureus and Pseudomonas aeruginosa.
Usage: This drug is indicated for treating steroid-responsive inflammatory conditions in ophthalmic (e.g., allergic conjunctivitis, iritis) and otic (e.g., allergic otitis externa) contexts, particularly when steroid use is warranted to reduce edema and inflammation. It also addresses corneal injuries and selected infective cases.
Usage: Fluocinolone Acetonide Oil 0.01% is indicated for treating chronic eczematous external otitis in adults and pediatric patients aged 2 years and older.
Usage: The drug is indicated for various skin conditions, including contact dermatitis, atopic dermatitis, eczema, impetigo, and folliculitis. It may also be effective for neurodermatitis, pruritus, and certain bacterial and fungal infections, though further investigation is needed for some less-established uses.
Usage: Ofloxacin otic solution, 0.3% is indicated for treating otitis externa in patients 6 months and older, chronic suppurative otitis media in those 12 and older with perforated tympanic membranes, and acute otitis media in pediatric patients 1 year and older with tympanostomy tubes due to specific bacteria.
Usage: Ofloxacin otic solution 0.3% is indicated for treating otitis externa in patients 6 months and older, chronic suppurative otitis media in patients 12 years and older with perforated tympanic membranes, and acute otitis media in pediatric patients with tympanostomy tubes.